Aspen Aerogels, Inc. (NYSE:ASPN) Given Consensus Rating of “Buy” by Analysts

Shares of Aspen Aerogels, Inc. (NYSE:ASPN) have received an average recommendation of “Buy” from the nine analysts that are currently covering the company, MarketBeat.com reports. Eight equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $29.11.

A number of research analysts recently weighed in on the stock. StockNews.com upgraded shares of Aspen Aerogels to a “sell” rating in a research note on Saturday, February 8th. Roth Mkm lowered their target price on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a research note on Friday, November 8th. Barclays lowered their target price on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 12th. Piper Sandler lowered their target price on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. Finally, Canaccord Genuity Group reduced their price target on shares of Aspen Aerogels from $28.00 to $20.00 and set a “buy” rating on the stock in a report on Thursday, January 16th.

Institutional Trading of Aspen Aerogels

Large investors have recently made changes to their positions in the business. nVerses Capital LLC increased its holdings in shares of Aspen Aerogels by 45.0% in the 3rd quarter. nVerses Capital LLC now owns 5,800 shares of the construction company’s stock worth $161,000 after buying an additional 1,800 shares during the last quarter. Quest Partners LLC increased its holdings in shares of Aspen Aerogels by 263.3% in the 3rd quarter. Quest Partners LLC now owns 7,397 shares of the construction company’s stock worth $205,000 after buying an additional 5,361 shares during the last quarter. Pursue Wealth Partners LLC bought a new stake in shares of Aspen Aerogels in the 3rd quarter worth about $222,000. Mesirow Financial Investment Management Inc. bought a new stake in shares of Aspen Aerogels in the 3rd quarter worth about $252,000. Finally, Kovitz Investment Group Partners LLC bought a new stake in shares of Aspen Aerogels in the 3rd quarter worth about $263,000. 97.64% of the stock is currently owned by institutional investors.

Aspen Aerogels Trading Down 23.7 %

Shares of Aspen Aerogels stock opened at $8.97 on Friday. The company’s fifty day simple moving average is $12.36 and its 200-day simple moving average is $18.63. The stock has a market capitalization of $735.58 million, a PE ratio of 897.40 and a beta of 2.14. Aspen Aerogels has a 1-year low of $8.43 and a 1-year high of $33.15. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48.

Aspen Aerogels (NYSE:ASPN) last released its earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, beating analysts’ consensus estimates of $0.04 by $0.11. Aspen Aerogels had a net margin of 0.36% and a return on equity of 5.06%. As a group, equities analysts anticipate that Aspen Aerogels will post 0.12 earnings per share for the current year.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.